BFC Planning’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
Other funds holding APGE
BFC Planning's APGE Position: Q3 2026 in Review
BFC Planning sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 200 shares — an estimated $26.5K sold.
BFC Planning first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $26.5K in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.
- BFC Planning reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
- BFC Planning sold 200 Apogee Therapeutics shares in Q3 2026, an estimated $26.5K.
- BFC Planning first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
- BFC Planning's Apogee Therapeutics position peaked at $26.5K in Q2 2026.
- 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.